Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 2561-2563, April 15, 2008. doi: 10.1158/0008-5472.CAN-07-6229
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Nagaraj, S.
Right arrow Articles by Gabrilovich, D. I.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagaraj, S.
Right arrow Articles by Gabrilovich, D. I.
Related Collections
Right arrow Tumor Biology
Right arrow Tumor Biology: Inflammation and Immune Escape
Right arrow Cancer Immunology: Innate Immunity

Reviews

Tumor Escape Mechanism Governed by Myeloid-Derived Suppressor Cells

Srinivas Nagaraj and Dmitry I. Gabrilovich

H. Lee Moffitt Cancer Center, University of South Florida, Tampa, Florida

Requests for reprints: Dmitry Gabrilovich, H. Lee Moffitt Cancer Center, University of South Florida, MRC-2, Room 2067, 12902 Magnolia Drive, Tampa, FL 33612. Phone: 813-903-6863; Fax: 813-632-1328; E-mail: dmitry.gabrilovich{at}moffitt.org.

Key Words: immune suppression • T cells • tumor immunology

T-cell nonresponsiveness is a critical factor in immune escape and myeloid-derived suppressor cells play a major role in organizing this phenomenon. Recent findings indicate that myeloid-derived suppressor cells can induce antigen-specific CD8+ T-cell tolerance through a posttranslation mechanism which involves modification (nitration) of CD8 and the T-cell receptor itself on the T-cell surface. Elucidation of this mechanism of T-cell tolerance offers new opportunities for therapeutic corrections of immune escape in cancer. [Cancer Res 2008;68(8):2561–63]




This article has been cited by other articles:


Home page
CRO ContentHome page
G. C. Prendergast
Risk Factors for Cancer: From Cell to Microenvironment
Cancer Reviews Online Content, May 1, 2008; 2008(5): 9 - 9.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.